Min, Joo-Ok
Strohäker, Timo
Jeong, Byung-Chul
Zweckstetter, Markus
Lee, Seung-Jae
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2018R1A5A2025964, NRF-2021R1A2C3012681)
Korea National Institute of Health (HI19C0256)
Deutsche Forschungsgemeinschaft (SFB860 (project B2))
Article History
Received: 3 January 2022
Accepted: 17 March 2022
First Online: 28 March 2022
Declarations
:
: All animal experiments were conducted according to protocols approved by Seoul National University (Republic of Korea) Institutional guidelines for the care and use of experimental animals (IACUC number: SNU-190721-1-10).
: Not applicable.
: S.-J.L is a founder and CEO of Neuramedy Co., Ltd. Other authors declare that they have no competing interests.